BioSpace36m
Pfizer Wins FDA Approval of RSV Vaccine for Broader Adult Population
Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.
Delta Optimist52m
As record number line up for shots, Henry says her role to serve whatever government is in power
The first day of flu and COVID shots set a single-day record, with 82,000 shots administered through B.C. pharmacies ...
kffhealthnews1h
Study Examines Respiratory Pattern’s Link To Anosmia, Other Health Issues
Sniff spikes, the study noted, might help researchers better understand some of the mental issues experienced by covid patients who have lost their sense of smell. Separately, researchers found that ...
The Pharma Letter46m
Roche’s strong sales growth continues
Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...
Take Charge of Your Health with Oncosure's Affordable Membership Plan
Oncosure is proud to introduce a membership plan that makes rapid cancer screening accessible to everyone. With just a simple blood draw, our all-in-one test screens for any type of cancer, detecting ...